On Tuesday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) opened lower -7.10% from the last session, before settling in for the closing price of $1.55. Price fluctuations for SLS have ranged from $0.77 to $2.48 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 45.94% annually for the last half of the decade. Company’s average yearly earnings per share was noted 46.00% at the time writing. With a float of $142.00 million, this company’s outstanding shares have now reached $142.44 million.
SELLAS Life Sciences Group Inc (SLS) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SELLAS Life Sciences Group Inc is 0.26%, while institutional ownership is 23.23%. The most recent insider transaction that took place on Nov 19 ’25, was worth 100,806. In this transaction Director of this company bought 63,400 shares at a rate of $1.59, taking the stock ownership to the 104,400 shares. Before that another transaction happened on Jun 12 ’25, when Company’s Director bought 10,000 for $1.48, making the entire transaction worth $14,800. This insider now owns 20,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.08 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.11) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.72% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Check out the current performance indicators for SELLAS Life Sciences Group Inc (SLS). In the past quarter, the stock posted a quick ratio of 8.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Let’s dig in a bit further. During the last 5-days, its volume was 2.83 million. That was better than the volume of 2.81 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 44.87%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 4.59%, which indicates a significant decrease from 17.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1110 in the past 14 days, which was lower than the 0.1242 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7493, while its 200-day Moving Average is $1.6043. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $1.5273. Second resistance stands at $1.6145. The third major resistance level sits at $1.6632. If the price goes on to break the first support level at $1.3914, it is likely to go to the next support level at $1.3427. Assuming the price breaks the second support level, the third support level stands at $1.2555.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are currently 142,442K shares outstanding in the company with a market cap of 205.12 million. Presently, the company’s annual sales total 0 K according to its annual income of -30,880 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,790 K.
